Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 7.6 Million Yuan Net Loss in First Quarter of 2023

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 7.6 million yuan in the first quarter of 2023, narrowing 73.8% year-on-year.

Meanwhile, the company posted 226.7 million yuan in revenue, up 14.1% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 902.2 million yuan in total liabilities, with a liability-to-asset ratio of 29.3%.